After more than fifteen years of activity, the company has reached a maturity level which led to the separation of its two historical activities with the creation of a subsidiary, totally and exclusively dedicated to its service activity.<\/p>\n
Since 2002, APTYS has exercised its galenic formulation activity based on patented technologies and analytical development as a service provider but also internally with the objective of providing licenses to third parties.<\/p>\n
Thus, in 2005, Bioalliance Pharma acquired the Loramyc\u00ae\/Oravig\u00ae rights, an oral bioadhesive form of miconazole for the treatment of oropharyngeal candidiasis. In 2013, Viramal acquired the Testocream\u00ae rights, a transdermal form of testosterone, for the treatment of hypogonadism.<\/p>\n
2017 was a significant year as APTYS obtained the pharmaceutical establishment status for its quality control activity. It signed a partnership agreement with Unither Pharaceuticals to develop an innovative product for pain treatment. Such innovation led to a co-funding venture including the Rh\u00f4ne-Alpes Region\/FEDER\/BPI.<\/p>\n
The year 2018 saw its qualification by the World Health Organization for its quality control activity, and the entry of a new investor into the company’s capital to continue funding the pain treatment project.<\/p>\n
<\/p>\n
APTYS PHARMACEUTICALS<\/span><\/strong> After more than fifteen years of activity, the company has reached a maturity level which led to the separation of its two historical activities with the creation of a subsidiary, totally and exclusively dedicated to its service activity. Since 2002, APTYS has exercised its galenic formulation activity based on patented technologies and analytical development as […]<\/p>\n","protected":false},"author":2,"featured_media":1793,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-1796","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\n
\nBiop\u00f4le Clermont-Limagne<\/span><\/strong>
\nPhone: +33 (0) 473 670 670
\nE-mail : contact@aptys-pharmaceuticals.com<\/a>
\nWeb site : www.aptys-pharmaceuticals.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"